Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart fa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart fa

Published:2008-02 Issue:2 Volume:10 Page:157-163
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Weir R.A.P.¹²,McMurray John J.V.¹²,Puu Margareta³,Solomon Scott D.⁴,Olofsson Bertil³,Granger Christopher B.⁵,Yusuf Salim⁶,Michelson Eric L.⁷,Swedberg Karl⁸,Pfeffer Marc A.⁴,

Affiliation:

1. Department of Cardiology; Western Infirmary; Glasgow G11 6NT United Kingdom

2. Faculty of Medicine; University of Glasgow; United Kingdom

3. AstraZeneca R&D; Mölndal Sweden

4. Brigham & Women's Hospital; Boston MA USA

5. Duke University Medical Center; Durham NC USA

6. HGM-McMaster Clinic; Hamilton Ontario Canada

7. AstraZeneca LP; Wilmington DE USA

8. Department of Medicine; Sahlgrenska University Hospital/Östra; Göteborg Sweden

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group;N Engl J Med,1987

2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators;N Engl J Med,1991

3. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators;Pitt;N Engl J Med,1999

4. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators;McKelvie;Circulation,1999

5. Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial;Cohn;Circulation,2003

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Heart Failure: Evolution of Concepts and Treatments;Cardiologia Croatica;2024-06

2. Multimodal efforts to slow the progression of chronic kidney disease in patients with type 2 diabetes mellitus;Journal of Diabetes and its Complications;2023-08

3. Pharmacological interventions for heart failure in people with chronic kidney disease;Cochrane Database of Systematic Reviews;2020-02-27

4. Effects of dual blockade in heart failure and renal dysfunction: Systematic review and meta-analysis;Journal of the Renin-Angiotensin-Aldosterone System;2019-10

5. Impacts of Predischarge Diastolic Functional Recovery on Clinical Outcomes in Patients With Hypertensive Heart Failure;Circulation Journal;2018-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3